News

Promising Results Released from Clinical Trial for MF Patients

MPN News | 1/7/19

According to a press release published by Constellation Pharmaceuticals, the latest findings in the Manifest Clinical Trial of CPI-0610 in Myelofibrosis Patients was found to have a profound effect on trial participants.

Read More

MPNRF Releases 2019 Request for Proposals

MPN News | 1/7/19

The MPN Research Foundation is proud to announce the opening of our 2019 call for proposals for the MPN Challenge Grant Program.

Read More

Breaking news for ropeginterferon

MPN News | 12.17.18

The CHMP has given a positive opinion on the drug and recommended granting market authorization.

Read More

MPN Highlights from ASH 2018

MPN News | 12/5/18

Each year the American Society of Hematology (ASH) hosts their annual convention, where researchers, doctors, and organizations such as the MPN Research Foundation gather to discuss the ever-changing world of blood disorders and learn about the progress of research.

Read More

MPNRF Founder Bob Rosen Honored as MPN Hero

MPN News | 12/1/18

The MPN Heroes Celebration Event held annually at ASH is an opportunity to recognize the individuals and organizations who work hard on behalf of the MPN community and make a difference in the lives of patients living with PV, ET, and MF. Each year at this event, recipients of the MPN Heroes Recognition Program are honored based on those actions and traits that define them as heroes. This year, on November 30, 2018, the founder of the MPN Research Foundation, Bob Rosen, was honored as one of those heroes.

Read More

MPNRF Funded Abstracts to be Presented at ASH

MPN News | 11/19/18

With your support, we have funded research that has resulted in gains in our understanding of Polycythemia Vera, Essential Thrombocythemia and Myelofibrosis. The publications linked below are funded by MPNRF and will be presented at the American Society of Hematology annual meeting in San Diego this December.

Read More

Study Assess Current Recommended Guidelines for the Treatment of PV Patients

MPN News | October 31, 2018
Read More

University of Michigan seeks to make bone marrow imaging less painful for people with myeloproliferative neoplasms

MPN News | October 23, 2018

Patients with an MPN are invited to participate in the non-invasive study

Read More

Ropeginterferon reduces JAK2 burden compared to Hydroxyurea in PV according to new study

MPN News | October 15, 2018

After 1 year of treatment with ropeginterferon, the ratio of JAK2-mutated to wild-type colonies grown from bone marrow progenitors was reduced by 64%, compared to 25% in patients receiving hydroxyurea.

Read More

Classification and Prognostic Models Developed for MPN Patient Outcomes

MPN News | 10/11/18
Read More

Increased Pentraxin-3 Correlates with the Activity of the Neoplastic Clone in Primary Myelofibrosis

MPN News | December 7, 2017

Increased Pentraxin-3 Correlates with the Activity of the Neoplastic Clone in Primary Myelofibrosis

Read More

FDA awards $18 million in grants for advancing treatment of rare diseases

MPN News | 10/3/18

The FDA announced on that they have awarded 12 new clinical trial research grants toward advancing the development of treatments of rare diseases.

Read More

Behind the Mystery: Living with Polycythemia Vera

MPN News

MPN experts Dr. Richard T. Silver, from New York - Presbyterian/Weill Cornell Medical Center, and Dr. Srdan Verstovsek of the MD Anderson Cancer Center, to discuss the latest in patient care and clinical trials for polycythemia vera, as well as the future for those living with PV as a chronic illness.

Read More

Janssen Elects Not to Continue Agreement with Geron for Imetelstat

MPN News

Today Janssen announced that they would no longer be partnering with Geron on the development of Imetelstat

Read More

MPN Research Foundation Attends 3rd Annual MPN Horizons Conference

MPN News | September 11, 2018

Director of Development, Bill Crowley, and Executive Director, Michelle Woehrle, represented MPN Research Foundation at the recent MPN Horizons 2018 Conference in Prague, Czech Republic.

Read More

Check our News - Archive for older news.

Get updates on MPN patients and research breakthroughs.

What are the latest developments in MPN Research?